Accessing the promise and potential of biosimilars

<p>James R Harris</p>

doi:10 .4172/2327-4581.1000411

Accessing the promise and potential of biosimilars

James R Harris

Healthcare Economics LLC, USA

: J Nephrol Ren Dis

Abstract

This presentation will cover the plight of biosimilar potential, challenges and opportunities within the USA. Of particular note will be the historical progress of biosimilars including but not limited to payer acceptance and provider perspectives on utilization and uptake. Additional focus will be place upon patient empowerment and access to these new therapies.